Trigyn Technologies reports ₹3.49 crore Q2 consolidated profit

Trigyn Technologies Limited reported a consolidated profit after tax of ₹3.49 crore for the quarter ended September 30, 2026, compared with a ₹4.61 crore loss a year earlier, while revenue increased 12.6% year-on-year to ₹252.76 crore. The results mark a return to profit on a consolidated basis in Q2 FY27.

What did Trigyn report for Q2 FY27?

Trigyn reported consolidated revenue from operations of ₹252.76 crore for Q2 FY27, compared with ₹224.50 crore in the corresponding quarter of the previous financial year. This represents year-on-year revenue growth of 12.6% for the July-to-September 2026 period.

The company recorded consolidated profit after tax from continuing operations of ₹3.49 crore, against a net loss after tax of ₹4.61 crore in Q2 FY26. The quarter also improved sequentially from a consolidated PAT of ₹0.63 crore in the preceding quarter. The results were approved as unaudited standalone and consolidated financial statements for the quarter and half-year ended September 30, 2026.

How did earnings change from the earlier periods?

Trigyn's Q2 FY27 profit represented a reversal from the loss reported in the corresponding quarter last year. Revenue also increased by ₹28.26 crore year-on-year, based on the figures disclosed in the company's results announcement.

The sequential comparison shows that Q2 PAT of ₹3.49 crore was above the ₹0.63 crore reported in the preceding quarter. Revenue was marginally higher than the preceding quarter's ₹251.95 crore. The supplied results disclosure does not provide a consolidated operating profit figure for Q2 FY27, so an operating-margin comparison cannot be drawn from this announcement.

What did the board approve alongside the financial results?

Trigyn's Board of Directors approved the unaudited standalone and consolidated results for the September 2026 quarter and half-year at its November 4 meeting. The company had earlier notified the market that the board would consider the financial results for the period ended September 30, 2026.

The board also approved the reconstitution of the Audit Committee and the Nomination and Remuneration Committee. The financial results underwent a limited review by the company's statutory auditors, M/s. V. Rohatgi & Co. The company said the results would be placed on its website and published in newspapers.

Why does the return to consolidated profit matter?

The move from a ₹4.61 crore loss in Q2 FY26 to a ₹3.49 crore profit in Q2 FY27 is the central financial development in the release. It indicates that the company generated a positive consolidated result from continuing operations while also recording higher revenue.

For investors, the comparison is relevant because revenue growth alone does not show whether a business is profitable. In this case, the year-on-year improvement includes both a 12.6% increase in revenue and a shift into positive PAT. The company has not provided a detailed explanation of the cost, pricing, project or other operating factors behind the change in the supplied information.

How do these figures affect investors and business operations?

The financial update provides the latest disclosed consolidated performance for Trigyn after the board meeting on November 4, 2026. The revenue level of ₹252.76 crore and positive PAT of ₹3.49 crore give investors two reported indicators to compare with future quarterly disclosures.

The audited status should also be considered when assessing the release. These are unaudited results subject to limited review, rather than final audited annual accounts. The announcement confirms the board's approval and the auditor's limited review, but it does not state any new operational target, dividend decision, order pipeline, guidance or management outlook.

Conclusion

Trigyn Technologies Limited returned to consolidated profitability in Q2 FY27, reporting PAT of ₹3.49 crore after a loss of ₹4.61 crore in the year-earlier quarter. Revenue rose 12.6% to ₹252.76 crore, while profit was also higher than the ₹0.63 crore reported in the preceding quarter.

The next point for investors is the company's subsequent financial disclosure, which can show whether revenue growth and positive consolidated PAT are sustained. The supplied results release does not disclose a forward target or operating guidance, leaving future quarterly filings as the key source for updated performance indicators.